Effect of combined training on breast cancer survivors

Authors
Category Primary study
Registry of TrialsIranian Registry of Clinical Trials
Year 2020
INTERVENTION: Intervention 1: Intervention group: 12 weeks of combined yoga and pilates training, three sessions per week, 75 minutes each session. Exercise training program consists of 10 minutes warming up, 30 minutes pilates training, 30 minutes yoga training and 5 minutes cooling down. Intervention 2: Control group: 12 weeks. routine daily activities. CONDITION: Multiple Sclerosis (MS). ; Multiple sclerosis PRIMARY OUTCOME: CA 125 tumor marker. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method. CA 15‐3 tumor marker. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method. CEA tumor marker. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method. Cortisol hormone. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method. Estrogen Hormone. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method. Fasting Blood Sugar. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Enzymatic method. SHBG. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method. Testosterone Hormone. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method. SECONDARY OUTCOME: HbA1C. Timepoint: Before and after the end of interventions. Method of measurement: Serum levels using Enzymatic method. Insulin hormone. Timepoint: Before and after the end of interventions. Method of measurement: Serum levels using Eliza method. Leptin hormon. Timepoint: Before and after the end of interventions. Method of measurement: Serum levels using Eliza method. INCLUSION CRITERIA: Ability to perform exercise training with oncologist approval underwent partial mastectomy termination of chemotherapy age between 35‐50
Epistemonikos ID: 2d14ae21dbef30b0d132844d85165eb714b2d554
First added on: Mar 31, 2022